Part 3/10:
Outlette is a medical technology firm aiming to make healthcare more accessible for parents of newborns. The company manufactures a sock-like device that monitors the heart rate and oxygen levels of infants. While it faced regulatory challenges from the FDA, Outlette has recently gained authorization to sell its products through pharmacies and major retailers, paving the way for significant expansion.
Despite its current market cap of only $76 million, success in various product offerings could drive this company to a valuation of $1 billion, representing a 10x potential.